公开(公告)号：US20160022449A1

公开(公告)日：2016-01-28

申请号：US14876661

申请日：2015-10-06

Applicant: Abbott Cardiovascular Systems, Inc.

Inventor： Florencia Lim ,  Mary Suh ,  Barbara Stamberg ,  Bin Huang

IPC: A61F2/88 ,  A61F2/90 ,  A61F2/958 ,  A61F2/844

CPC classification number: A61F2/885 ,  A61F2/04 ,  A61F2/186 ,  A61F2/20 ,  A61F2/844 ,  A61F2/88 ,  A61F2/90 ,  A61F2/95 ,  A61F2/958 ,  A61F2/962 ,  A61F2002/043 ,  A61F2002/044 ,  A61F2002/046 ,  A61F2210/0004 ,  A61F2210/0076 ,  A61F2220/0008 ,  A61F2230/0069 ,  A61F2230/0091 ,  A61F2250/0015 ,  A61F2250/0018 ,  A61F2250/0028 ,  A61F2250/0039 ,  A61F2250/0067 ,  A61F2250/0098

Abstract: Devices and methods for treating a diseased tracheobronchial region in a mammal. The device can be a stent which can include a sustained-release material such as a polymer matrix with a treatment agent. The stent can be bioabsorbable and a treatment agent can be incorporated therewith. A treatment method can be delivery of a stent to a tracheobronchial region by a delivery device such as a catheter assembly.

Abstract translation: 用于治疗哺乳动物患病气管支气管区域的装置和方法。 该装置可以是可以包括缓释材料如具有治疗剂的聚合物基质的支架。 支架可以是生物可吸收的，并且可以并入治疗剂。 治疗方法可以是通过诸如导管组件的递送装置将支架递送到气管支气管区域。

公开(公告)号：US09833342B2

公开(公告)日：2017-12-05

申请号：US14876661

申请日：2015-10-06

Applicant: Abbott Cardiovascular Systems Inc.

Inventor： Florencia Lim ,  Mary Suh ,  Barbara Stamberg ,  Bin Huang

IPC: A61F2/04 ,  A61F2/88 ,  A61F2/844 ,  A61F2/90 ,  A61F2/958 ,  A61F2/18 ,  A61F2/20 ,  A61F2/95 ,  A61F2/962

CPC classification number: A61F2/885 ,  A61F2/04 ,  A61F2/186 ,  A61F2/20 ,  A61F2/844 ,  A61F2/88 ,  A61F2/90 ,  A61F2/95 ,  A61F2/958 ,  A61F2/962 ,  A61F2002/043 ,  A61F2002/044 ,  A61F2002/046 ,  A61F2210/0004 ,  A61F2210/0076 ,  A61F2220/0008 ,  A61F2230/0069 ,  A61F2230/0091 ,  A61F2250/0015 ,  A61F2250/0018 ,  A61F2250/0028 ,  A61F2250/0039 ,  A61F2250/0067 ,  A61F2250/0098

Abstract: Devices and methods for treating a diseased tracheobronchial region in a mammal. The device can be a stent which can include a sustained-release material such as a polymer matrix with a treatment agent. The stent can be bioabsorbable and a treatment agent can be incorporated therewith. A treatment method can be delivery of a stent to a tracheobronchial region by a delivery device such as a catheter assembly.